Giving a Voice to Patients With GI Cancers
Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.
Martha Raymond, founder and CEO of the Raymond Foundation, discusses how her organization helps to provide a voice for patients with gastrointestinal (GI) cancers.
After losing both her parents to colon cancer, Raymond founded the Raymond Foundation to provide outreach and support to patients with the disease.
Now, the Raymond Foundation serves patients with all kinds of GI cancers by going into the communities and talking to patients and caregivers to better understand what needs they feel are being unmet. The foundation then takes that information to universities, hospitals and medical centers, where larger programs can be established to address these needs.
Identifying and Addressing the Barriers to Clinical Trial Access
January 21st 2021This week on the “CURE® Talks Cancer” podcast, we spoke with Martha Raymond, of The Raymond Foundation, about how providers can ensure patient safety to increase trial enrollment during the COVID-19 pandemic, and what she and her colleagues are doing to provide better trial access to all patients with cancer.
Listen
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More
